Page last updated: 2024-10-31

midodrine and Erythromelalgia

midodrine has been researched along with Erythromelalgia in 1 studies

Midodrine: An ethanolamine derivative that is an adrenergic alpha-1 agonist. It is used as a vasoconstrictor agent in the treatment of HYPOTENSION.
midodrine : An aromatic ether that is 1,4-dimethoxybenzene which is substituted at position 2 by a 2-(glycylamino)-1-hydroxyethyl group. A direct-acting sympathomimetic with selective alpha-adrenergic agonist activity, it is used (generally as its hydrochloride salt) as a peripheral vasoconstrictor in the treatment of certain hypotensive states. The main active moiety is its major metabolite, deglymidodrine.

Erythromelalgia: A peripheral arterial disease that is characterized by the triad of ERYTHEMA, burning PAIN, and increased SKIN TEMPERATURE of the extremities (or red, painful extremities). Erythromelalgia may be classified as primary or idiopathic, familial or non-familial. Secondary erythromelalgia is associated with other diseases, the most common being MYELOPROLIFERATIVE DISORDERS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Davis, MD1
Morr, CS1
Warndahl, RA1
Sandroni, P1

Other Studies

1 other study available for midodrine and Erythromelalgia

ArticleYear
Topically Applied Midodrine, 0.2%, an α1-Agonist, for the Treatment of Erythromelalgia.
    JAMA dermatology, 2015, Volume: 151, Issue:9

    Topics: Administration, Topical; Adrenergic alpha-1 Receptor Agonists; Adult; Aged; Diagnosis, Differential;

2015